• 1
    Ducy P, Schinke T, Karsenty G 2000 The osteoblast: A sophisticated fibroblast under central surveillance. Science 289:15011504.
  • 2
    Kong YY, Yoshida H, Sarosi I, Tan HL, Timms E, Capparelli C, Morony S, Oliveira-dos-Santos AJ, Van G, Itie A, Khoo W, Wakeham A, Dunstan CR, Lacey DL, Mak TW, Boyle WJ, Penninger JM 1999 OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397:315323.
  • 3
    Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, Hsu H, Sullivan J, Hawkins N, Davy E, Capparelli C, Eli A, Oian YX, Kaufman S, Sarosi I, Shalhoub V, Senaldy G, Guo J, Delaney J, Boyle WJ 1998 Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93:165176.
  • 4
    Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, Tomoyasu A, Yano K, Goto M, Murakami A, Tsuda E, Morinaga T, Higashio K, Udagawa N, Takahashi N, Suda T 1998 Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 95:35973602.
  • 5
    Akatsu T, Murakami T, Nishakawa N, Ono K, Shinomiya N, Tsuda E, Mochizuki S, Yamaguchi K, Kinosaki M, Higashio K, Yamamoto M, Motovoshi K, Nagata N 1998 Osteoclastogenesis-inhibitory factor suppresses osteoclast survival by interfering in the interaction of stromal cells with osteoclasts. Biochem Biophys Res Commun 250:229234.
  • 6
    Ukai T, Hara Y, Kato I 1996 Effects of T-cell adoptive transfer into nude mice on alveolar bone resorption induced by endotoxin. J Periodontal Res 31:414422.
  • 7
    Hara Y, Ukai T, Yoshimura A, Shiku H, Kato I 1998 Histopathological study on the role of CD4- and CD8-positive T-cells on bone resorption induced by Escherichia coli entotoxin. Calcif Tissue Int 63:6366.
  • 8
    Weitzmann MN, Cenci S, Rifas L, Haug J, Dipersio J, Pacifici R 2001 T-cell activation induces human osteoclast formation via receptor activator of nuclear factor κB ligand-dependent and independent mechanisms. J Bone Miner Res 16:328337.
  • 9
    Theill LE, Boyle WJ, Penninger JM 2002 RANKL and RANK: T-cells, Bone loss and mammalian evolution. Annu Rev Immunol 20:795823.
  • 10
    Teng YA, Nguyen H, Gao X, Kong Y, Gorczynski RM, Singh B, Ellen RP, Penninger JM 2000 Functional human T-cell immunity and osteoprotegerin ligand control alveolar bone destruction in periodontal infection. J Clin Invest 106:5967.
  • 11
    Taubman MA, Kawai T 2001 Involvement of T-lymphocytes in periodontal disease and in direct and indirect induction of bone resorption. Crit Rev Oral Biol Med 12:125135.
  • 12
    Cahalan MD, Chandy KG 1998 Ion channels in the immune system as targets for immunosuppression. Curr Opin Biotechnol 8:749756.
  • 13
    Koo GC, Blake JT, Talento A, Nguyen M, Lin S, Sirotina A, Shah K, Mulvany K, Hora D Jr, Cunningham P, Wunderler DL, McManus OB, Slaughter R, Bugianesi R, Felix J, Garcia M, Williamson J, Kaczorowski G, Sigal NH, Springer MS, Feeney W 1997 Blockade of the voltage-gated potassium channel Kv1.3 inhibits immune responses in vivo. J Immunol 158:51205128.
  • 14
    Koo GC, Blake JT, Shah K, Staruch MJ, Dumont F, Wunderler D, Sanchez M, McManus OB, Sirotina-Meisher A, Fisher P, Boltz RC, Goetz MA, Baker R, Bao J, Kayser F, Rupprecht KM, Parsons WH, Tong XC, Ita IE, Pivnichny J, Vincent S, Cunningham P, Hora D Jr, Feeney W, Kaczorowski G, Springer MS 1999 Correolide and derivatives are novel immunosuppressants blocking the lymphocyte Kv1.3 potassium channels. Cell Immunol 197:99107.
  • 15
    Beeton C, Barbaria J, Giraud P, Devaux J, Benoliel A, Gola M, Sabatier JM, Bernard D, Crest M, Beraud E 2001 Selective blocking of voltage-gated K+ channels improves experimental autoimmune encephalomyelitis and inhibits T-cell activation. J Immunol 166:936944.
  • 16
    Beeton C, Wulff H, Barbaria J, Clot-Faybesse O, Pennington M, Bernard D, Cahalan MD, Chandy KG, Beraud E 2001 Selective blockade of T lymphocyte K+ channels ameliorates experimental autoimmune encephalomyelitis, a model for multiple sclerosis. Proc Natl Acad Sci USA 98:1394213947.
  • 17
    Kawai T, Eisen-Lev R, Seki M, Eastcott JW, Wilson ME, Taubman MA 2000 Requirement of B7 costimulation for Th1-mediated inflammatory bone resorption in experimental periodontal disease. J Immunol 164:21022109.
  • 18
    Kong YY, Feige U, Sarosi I, Bolon B, Tafuri A, Moroni S, Capparelli C, Li J, Elliott R, McCabe S, Wong T, Campagnuolo G, Moran E, Bogoch ER, Van G, Nguyen LT, Ohashi PS, Lacey DL, Fish E, Boyle WJ, Penninger JM 1999 Activated T-cells regulate bone loss and joint destruction in arthritis via OGPL. Nature 402:304309.
  • 19
    Wang R, Zhang L, Shang X, Moreno J, Celluzzi C, Tondravi M, Shi Y 2002 Regulation of activation-induced receptor activator of NF-kB ligand (RANKL) expression in T-cells. Eur J Immunol 32:10901098.
  • 20
    Kawai T, Shimauchi H, Eastcott JW, Smith DJ, Taubman MA 1998 Antigen direction of specific T-cell clones into gingival tissues. Immunology 93:1119.
  • 21
    Komatsuzawa H, Kawai T, Wilson M, Taubman MA, Sugai M, Siginaka H 1999 Cloning of the gene encoding the Actinobacillus actinomycetemcomitans serotype b OmpA-like outer membrane protein. Infect Immun 67:942945.
  • 22
    Perry MB, MacLean MM, Gmur R, Wilson ME 1996 Characterization of the O-polysaccharide structure of lipopolysaccharide from Actinobacillus actinomycetemcomitans serotype b. Infect Immun 64:12151219.
  • 23
    Kawai T, Seki M, Hiromatsu K, Eastcott JW, Watts GF, Sugai M, Smith DJ, Porcelli SA, Taubman MA 1999 Selective diapedesis of Th1 cells induced by endothelial cell RANTES. J Immunol 163:32693278.
  • 24
    Chen W, Li YP 1998 Generation of mouse osteoclastogenic cell lines immortalized with SV40 large T antigen. J Bone Miner Res 13:11121123.
  • 25
    Kamolmatyakul S, Chen W, Li YP 2001 Interferon-gamma down-regulates gene expression of cathepsin K in osteoclasts and inhibits osteoclast formation. J Dent Res 80:351355.
  • 26
    Ishida Y, Chused TM 1993 Lack of voltage sensitive potassium channels and generation of membrane potential by sodium potassium ATPase in murine T lymphocytes. J Immunol 151:610620.
  • 27
    Mahaut-Smith MP, Mason MJ 1991 Ca(2+)-activated potassium channel in rat thymic lymphocytes: Activation by concanavalin A. J Physiol 439:513528.
  • 28
    Epstein S 1996 Post-transplantation bone disease: The role of immunosuppressive agents and the skeleton. J Bone Miner Res 11:17.
  • 29
    Cvetkovic M, Mann GN, Romero DF, Liang XG, Ma Y, Jee WS, Epstein S 1994 The deleterious effects of long-term cyclosporin A, cyclosporine G, and FK-506 on bone mineral metabolism in vivo. Transplantation 57:12311237.
  • 30
    Movsowitz C, Epstein S, Ismail F, Fallon M, Thomas S 1989 Cyclosporin A in the oophorectomized rat: Unexpected severe bone resorption. J Bone Miner Res 4:393398.
  • 31
    Epstein S 1991 Cyclosporine friend or foe? Calcif Tissue Int 49:232234.
  • 32
    Hofbauer LC, Shue C, Riggs BL, Dunstan CR, Spelsberg TC, O'Brian T, Khosla S 2001 Effects of immunosuppressants on receptor activator of NF-κB ligand and osteoprotegerin production by human osteoblastic and coronary artery smooth muscle cells. Biochem Biophys Res Commun 280:334339.
  • 33
    Levite M, Cahalon L, Peretz A, Hershkoviz R, Sobko A, Ariel A, Desai R, Attali B, Lider O 2000 Extracellular K(+) and opening of voltage-gated potassium channels activate T-cell integrin function: Physical and functional association between Kv1.3 channels and beta1 integrins. J Exp Med 191:11671176.
  • 34
    Komarova SV, Dixon SJ, Sims SM 2001 Osteoclast ion channels: Potential targets for antiresorptive drugs. Curr Pharm Des 7:637654.
  • 35
    Rousselle AV, Heymann D 2002 Osteoclastic acidification pathways during bone resorption. Bone 30:533540.